Facebook Inc’s (NASDAQ:FB) IPO Victims To Be Compensated Next Week


The boards of the Nasdaq Stock Market and the NASDAQ OMX Group, Inc. (NASDAQ:NDAQ) are preparing to introduce a compensation plan for brokerages that faced losses during the Facebook Inc (NASDAQ:FB) botched IPO.

The FOX Business channel reported citing sources that the new compensation expected to be unveiled next week could be as high as $100 million or £64 million, higher from the $40 million or £26 million that was at first revealed by the exchange, but still considerably short of the $350 million or £225 million reported losses. The NASDAQ Composite (INDEXNASDAQ:.IXIC) opened higher but then hit intraday low of 2,873.50 and, at last check, was down 0.48%.

 

Gentex Corporation (NASDAQ:GNTX)

Gentex Corporation reported financial results for the second quarter and first six months ended June 30, 2012. For the second quarter of 2012, the Company’s net sales jumped by 15 percent to $280.3 million compared with $243.0 million in the second quarter of 2011. Net income for the second quarter of 2012 increased six percent to $40.8 million.

Gentex Corporation (NASDAQ:GNTX) declined -26.67% to $15.52 with total traded volume of 8.92 million shares in mid day trading. Stock price 52 weeks high was $32.21 and 52 weeks low price was $15.87. GNTX has market capitalization of 2.32 billion.

[article_detail_ad_1]

Sarepta Therapeutics Inc (NASDAQ:SRPT)

Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) skyrocketed to +150.00% in mid day trading to close at $8.71 with the total traded volume of 8.71 million shares following its news that Sarepta Therapeutics revealed the first data signifying that an experimental “genetic fix” can considerably perk up the walking performance of patients with muscular dystrophy.

SRPT has outstanding shares of 22.62 million with the total market capitalization of 197.05 million and its beta value stands at 1.18 times. Sarepta Therapeutics Inc., formerly AVI BioPharma, Inc., is a biopharmaceutical company focused on the discovery and development of ribonucleic acid (RNA)-based therapeutics

 

Cisco Systems, Inc. (NASDAQ:CSCO)

The largest maker of equipment for computer networks, Cisco Systems Inc. (CSCO), won European Union endorsement to purchase digital-video company NDS Group Ltd. in an agreement valued at about $5 billion.

During mid day trading, Cisco Systems, Inc. (NASDAQ:CSCO) slipped -5.82% with the closing price of $15.13 and total traded volume was 45.40 million shares. Its fifty two week range was $13.30-$21.30. The total market capitalization remained $81.05 billion.

CSCO is ahead its 52 week low with 15.80% and its last month price volatility remained 2.24%. Its beta coefficient was 1.25 with a target price of $21.16.

 


Leave a Reply

Your email address will not be published. Required fields are marked *